StockMarketWire.com - Futura Medical said it expected to commence first patient dosing of its topical gel for erectile dysfunction, known as MED2002, by the end of September.

Feedback from potential commercial partners had highlighted a desire from some men for a faster-acting treatment than existing pill options, the company said.

'Completion of a significant out-licensing agreement for MED2002 remains a top priority for the company and, whilst negotiations proceed, we will continue to maintain the momentum in the product's development,' Futura said.

Story provided by StockMarketWire.com